Peter A Clemens Acura Pharmaceuticals, Inc (ACUR) insider trading activity

Peter A Clemens is Senior VP & CFO of ACURA PHARMACEUTICALS, INC. Currently has a direct ownership of 545,430 shares of ACUR, which is worth approximately $0. The most recent transaction as insider was on Nov 20, 2023, when has been sold 40,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 545K

0% 3M change

0% 12M change

Total Value Held $0

PETER A CLEMENS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2023	BUY Exercise of conversion of derivative security	-	40,000 Added 6.83%	545,430 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	40,000 Added 7.33%	505,430 Common Stock
Aug 03 2022	BUY Exercise of conversion of derivative security	-	49,333 Added 9.58%	465,430 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$6,040 $0.4 p/Share	15,100 Reduced 3.5%	416,097 Common Stock
Feb 24 2021	BUY Exercise of conversion of derivative security	$6,000 $0.15 p/Share	40,000 Added 8.49%	431,197 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$4,098 $0.21 p/Share	19,514 Reduced 4.75%	391,197 Common Stock
Jan 04 2021	BUY Exercise of conversion of derivative security	-	49,334 Added 10.72%	410,711 Common Stock

PAC

Peter A Clemens

Senior VP & CFO

Palatine, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACUR shares.

Notify only if

Value

Insider Trading

Get notified when an Acura Pharmaceuticals, Inc insider buys or sells ACUR shares.

Notify only if

Operation

Value

Type

News

Receive news related to ACURA PHARMACEUTICALS, INC

Track Activities on ACUR

Account